Empyrean Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$74.3M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$71.2M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$59.1M |
| 4 |
Williams Companies
WMB
|
+$49.3M |
| 5 |
DigitalBridge
DBRG
|
+$48.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$100M |
| 2 |
AGN
Allergan Inc
AGN
|
+$84.6M |
| 3 |
Air Products & Chemicals
APD
|
+$83.6M |
| 4 |
AGN
Allergan plc
AGN
|
+$70.9M |
| 5 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$59.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.36% |
| 2 | Healthcare | 10.54% |
| 3 | Communication Services | 7.1% |
| 4 | Financials | 6.51% |
| 5 | Energy | 5.7% |
Similar funds
Empyrean Capital Partners's Q3 2014 Portfolio in Review
As of Q3 2014, Empyrean Capital Partners held 74 positions worth $2.83B, down 0.35% from $2.84B the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Empyrean Capital Partners withdrew a net $206M in Q3 2014, closing 23 positions and reducing 8 holdings. Its most notable exit was Yahoo Inc, an estimated $100M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 57% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Empyrean Capital Partners opened a new position in AbbVie worth $77.3M.
- Empyrean Capital Partners's largest Q3 2014 buy was AbbVie: 1,337,600 shares worth $77.3M.
- Empyrean Capital Partners added most to Paramount Global Class B in Q3 2014, an estimated $59.1M increase.
- Empyrean Capital Partners's biggest Q3 2014 reduction was Liberty Media Series A, cutting an estimated $37.8M.
- Empyrean Capital Partners fully exited Yahoo Inc in Q3 2014, selling an estimated $100M.
- Empyrean Capital Partners's ten largest holdings make up 65% of its $2.83B portfolio in Q3 2014.
- Empyrean Capital Partners opened 18 new positions and closed 23 in Q3 2014.
- Empyrean Capital Partners's portfolio value fell 0.35% quarter-over-quarter to $2.83B.
Based on Empyrean Capital Partners's 13F filing for Q3 2014, filed 14 Nov 2014.